Higher HDL-C linked to better cognition in older DM patients

June 2, 2018

(HealthDay)—Higher serum high-density lipoprotein cholesterol (HDL-C) is associated with better executive function among older patients with diabetes mellitus (DM), according to a study published online May 19 in the Journal of Diabetes Investigation.

Yue Sun, from the Chinese University of Hong Kong, and colleagues conducted a secondary analysis of a vitamin B12 intervention trial involving 271 non-demented older people with DM. The authors sought to assess the association between baseline clinical features and changes in cognitive measures over 27 months.

The researchers found that, at baseline, 152 subjects were cognitively normal and 119 were cognitively impaired. Over the study period, 41 subjects had cognitive decline, 36 of whom were cognitively normal at baseline. There was no significant clinical predictor of global cognitive decline. However, higher HDL-C was associated with better executive performance at follow-up (P < 0.001). In multilevel modeling, the highest tertile of HDL-C was shown to be associated with better executive function z scores than the lowest tertile of HDL-C, at all time points.

"In summary, no significant clinical factor for cognitive decline in older people with DM was found in this study," the authors write. "Higher serum HDL-C levels were associated with better performance in executive function. Elucidation of the underlying mechanisms of this association may lead to effective prevention strategies to prevent in older people with DM."

Explore further: New research shows diabetes and worse blood sugar control are associated with long-term cognitive decline

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New research shows diabetes and worse blood sugar control are associated with long-term cognitive decline

January 25, 2018
A new study of some 5,000 older people in the UK has shown that rates of long-term cognitive decline are steeper in those who have diabetes compared with people with normal blood sugar control, and that efforts to delay the ...

Late, but not too late—screening for olfactory dysfunction

April 20, 2018
In a large population-based study of randomly selected participants in Germany, researchers found that participants aged 65-74 years with olfactory dysfunction showed impaired cognitive performance. Interestingly, this strong ...

Accelerated cognitive decline seen with T2DM in middle age

January 21, 2013
(HealthDay)—Middle-aged patients with type 2 diabetes show accelerated cognitive decline in information processing speed and executive function, according to a study published online Dec. 28 in Diabetes Care.

Blood sodium levels may affect cognition in older adults

February 8, 2018
A new study has found that lower level of sodium in the blood—known as hyponatremia—is linked with declines in cognitive function with advancing age. The results, which are described in an upcoming issue of the Clinical ...

Review links albuminuria to cognitive impairment, dementia

February 13, 2017
(HealthDay)—Albuminuria is associated with cognitive impairment, dementia, and cognitive decline, according to a review published online Feb. 2 in the Journal of the American Geriatrics Society.

Retinopathy associated with accelerated cognitive decline

March 1, 2018
(HealthDay)—Retinopathy is associated with accelerated rates of 20-year cognitive decline, according to a study published online Feb. 28 in Neurology.

Recommended for you

Eye conditions provide new lens screening for Alzheimer's disease

August 8, 2018
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

Potential indicator for the early detection of dementias

August 7, 2018
Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions ...

pH imbalance in brain cells may contribute to Alzheimer's disease

August 2, 2018
Johns Hopkins Medicine scientists say they have found new evidence in lab-grown mouse brain cells, called astrocytes, that one root of Alzheimer's disease may be a simple imbalance in acid-alkaline—or pH—chemistry inside ...

Newly characterized molecule offers possibilities for novel Alzheimer's treatments

August 2, 2018
Alzheimer's disease is an increasingly prevalent, neurodegenerative condition that erodes memory and other cognitive functions. Treatments for this complex disease have been elusive, although researchers have previously uncovered ...

Alzheimer's drug may stop disease if used before symptoms develop

August 1, 2018
About 50 percent of people who reach the age of 85 will develop Alzheimer's disease. Most will die within about five years of exhibiting the hallmark symptoms of the disease – severe memory loss and a precipitous decline ...

Microfluidic system incorporates neuroinflammation into 'Alzheimer's in a dish' model

July 30, 2018
Building on their development of the first culture system to replicate fully the pathology behind Alzheimer's disease, a Massachusetts General Hospital (MGH) research team has now produced a system that includes neuroinflammation, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.